ZBTB20 is involved in liver regeneration after partial hepatectomy in mouse
 
Ming-Zhe Weng, Peng-Yuan Zhuang, Zhen-Yu Hei, Pei-Yi Lin, Zhi-Sheng Chen, Ying-Bin Liu, Zhi-Wei Quan and Zhao-Hui Tang
Shanghai, China
 
 
Author Affiliations: Department of General Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China (Weng MZ, Zhuang PY, Hei ZY, Lin PY, Chen ZS, Liu YB, Quan ZW and Tang ZH)
 
Corresponding Author: Zhao-Hui Tang, MD, PhD, Department of General Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, No. 1665 Kongjiang Street, Shanghai 200092, China (Tel/Fax: 86-21-25078999; Email: tangzhaohui@yahoo.com)
 
© 2014, Hepatobiliary Pancreat Dis Int. All rights reserved.
doi: 10.1016/S1499-3872(14)60006-0
 
 
Contributors: TZH proposed the study. WMZ and TZH performed research and wrote the first draft. WMZ collected and analyzed the data. All authors contributed to the design and interpretation of the study and to further drafts. TZH is the guarantor.
Funding: This study was supported by a grant from the Shanghai Municipal Commission of Education Scientific Research and Innovation Project (11zz107).
Ethical approval: This study was approved by Ethics Committee of Xinhua Hospital, Shanghai Jiaotong University School of Medicine.
Competing interest: No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.
 
 
BACKGROUND: A better understanding of the molecular mechanisms in liver regeneration holds promise for exploring the new potential therapy for liver failure. The present study was to investigate the role of zinc finger and BTB domain-containing protein 20 (ZBTB20), a potential factor associated with liver regeneration, in a model of 70% hepatectomy in mice.
 
METHODS: Parameters for liver proliferation such as liver/body ratio and BrdU positivity were obtained via direct measurement and immunohistochemistry. The levels of zinc fingers and homeoboxes 2 (ZHX2), ZBTB20, alpha-fetoprotein (AFP) and glypican 3 (GPC3) transcripts in the regenerating liver tissue of a 70% hepatectomy rodent model were monitored by real-time PCR analysis at different time points. Knockdown of ZBTB20 was performed to characterize its regulatory function.
 
RESULTS: A negatively regulating relationship between ZHX2, ZBTB20 and AFP, GPC3 was revealed from 24 to 72 hours after 70% hepatectomy. ZBTB20 appears to negatively regulate AFP and GPC3 transcription since the knockdown of ZBTB20 promoted the proliferation of hepatocytes and the expression of AFP and GPC3.
 
CONCLUSION: In addition to AFP, GPC3 and ZHX2, ZBTB20 is a new regulator in liver regeneration and the decrease of ZBTB20 expression following 70% hepatectomy promotes AFP and GPC3 expression.
 
(Hepatobiliary Pancreat Dis Int 2014;13:48-54)
 
KEY WORDS: partial hepatectomy; liver regeneration; ZBTB20; mouse
 
 
Introduction
The liver can functionally recover from hepatic injury such as surgery, trauma, poisoning, infection, and so on, which indicates that the liver possesses remarkable regenerative capabilities. A better understanding of the molecular mechanisms in liver regeneration helps to find a potential effective therapy for liver failure. Partial hepatectomy of rodent model has been extensively utilized for investigating this highly precise molecular regulation, which has led to the identification of many factors necessary for liver regeneration.[1]
 
Alpha-fetoprotein (AFP), a major plasma protein produced by the yolk sac and the liver during fetal development, is thought to be the fetal form of serum albumin.[2, 3] Glypicans are a small family of glycosylphosphatidylinositol-anchored heparin sulfate proteoglycans,[4] which is associated with cell growth, development and responses to various growth factors. Among different glypicans, X-linked glypican 3 (GPC3) has been associated with certain tumors such as breast and ovarian tumors and mesotheliomas.[5-7] AFP and GPC3 are expressed in fetal liver but not in adult liver, they are reactivated in hepatocellular carcinoma and therefore, are the markers of hepatocellular carcinoma.[8] Furthermore, their levels are elevated in the regenerating liver and they are the markers of liver regeneration.[9-11]
 
The correlation between zinc fingers and homeoboxes 2 (ZHX2) and AFP was noticed in BALB/cJ mice.[12,13] Loss of the ZHX2 gene in BALB/cJ mice leads to incomplete silencing of its target AFP, and the AFP mRNA level is about 10-20 times more in BALB/cJ mice than that in other strains. This suggests that ZHX2 negatively regulates AFP. In addition, Morford et al[14] reported that GPC3 was up-regulated in the liver of BALB/cJ mice and this trend could be reversed by transfecting the ZHX2 gene into BALB/cJ mice, which indicates that ZHX2 could also repress GPC3 expression.
 
Another zinc finger family protein−zinc finger and BTB domain-containing protein 20 (ZBTB20) was also found to be activated in fetal liver and its expression inversely correlated with AFP gene expression.[15] However, it is not clear whether ZBTB20 plays a role in the regulation of AFP and GPC3 gene transcription during liver regeneration.
 
The present study was to elucidate some of the molecular mechanisms of liver regeneration. We used a partial hepatectomy in mice to observe the relationships between regeneration-related genes (AFP and GPC3) and two zinc finger protein genes (ZHX2 and ZBTB20).
 
 
Methods
ZBTB20 siRNA-expressing adenovirus
Adenoviruses were created with the Ad Easy System from Stratagene Biotechnology (La Jolla, CA, USA). siRNA-expressing adenovirus targeting mouse ZBTB20 was constructed according to the manufacturer's instructions. Briefly, one pair of oligonucleotides targeting mouse ZBTB20 mRNA was synthesized by Sangon Biotech (Shanghai, China). The dsDNA was ligated between the BamHI and HindIII sites on the pShuttle containing H1 promoter and GFP sequences. The control (mock) vector was constructed by inserting oligonucleotides that include a siRNA with limited homology to sequences in the mouse genome. Adenoviral DNA was prepared on a large scale in Escherichia coli DH5α, generating Ad/ZBTB20 siRNA and Ad/siRNA. All adenoviruses were packaged in HEK293 cells and purified using Adeno-X™ purification kit (BD Biosciences Clontech, Mountain View, CA, USA). Viral titers were determined using Adeno-X™ rapid titer kit from the same company.
 
Cell culture and transfection
Mouse hepatocyte cell line TIB-73 (from the Chinese Academy of Sciences, Shanghai, China) was used. The cells were cultured in RPMI 1640 medium (HyClone Laboratories Inc., Logan, UT, USA) supplemented with 10% fetal bovine serum (HyClone Laboratories Inc., Logan, UT, USA), 100 U/mL penicillin and 100 mg/mL streptomycin, and were incubated in a 5% CO2 atmosphere at 37 ��. TIB-73 cells were infected with the Ad/ZBTB20 siRNA at 50 PFU/cell, and TIB-73 cells infected with Ad/siRNA were used as controls. Adenovirus generation was confirmed by the expression of GFP. For cell growth curves, TIB-73, TIB-73+Ad/siRNA and TIB-73+Ad/ZBTB20 siRNA were harvested and reseeded at 1×104 cells/well in 12-well plates. The total cell number was determined every day with a hematocytometer and by using an inverted microscope (Olympus, Tokyo, Japan).
 
Animal husbandry and surgery
C57BL/6J mice (age 6-10 weeks, body weight 20-30 g) were obtained from the Shanghai Laboratory Animal Center of the Chinese Academy of Sciences (Shanghai, China). The mice were housed in groups of three to five in a vivarium maintained on a 12-hour light/dark cycle with a temperature of 22±1 �� and a relative humidity of 50±5%. All mice were divided into two groups: major hepatectomy (70% partial hepatectomy) group and minor hepatectomy (5% partial hepatectomy) group (n=35 in each group). Major hepatectomy was performed under general anesthesia (4% chloral hydrate at a dose of 8 µL/g, intraperitoneal injection) and the left lateral, left middle and right middle lobes were removed (Fig. 1). Minor hepatectomy was performed with the resection of the left middle lobe was resected. The removed liver during the surgery was considered as sample at 0 hour. At each time point (2, 4, 24, 48, 72, 96 and 168 hours) after surgery, 5 animals were sacrificed by CO2 inhalation and liver tissues were harvested. All procedures were carried out in accordance with the guidelines of the Ethics Committee of Xinhua Hospital, Shanghai Jiaotong University School of Medicine.
 
Liver tissue collection, histology and immunohisto­chemistry
At each time point after the surgery, regenerating liver samples were collected and liver weights were measured. The liver/body weight ratio (%) was calculated to evaluate regeneration. Bromodeoxyuridine (BrdU) labeling was used to identify hepatocytes within S-phase. Briefly, 100 mg BrdU (Dako Corp., Carpinteria, CA, USA) per kg of body weight was injected intraperitoneally 30 minutes before the animals were euthanized. The parafin-embedded liver tissue was cut into 6-µm sections, deparafinized, and cooked in a microwave oven for 10 minutes in Tris-buffered citric acid (pH=6) for antigen retrieval. BrdU incorporation was detected immunohistologically using a monoclonal anti-BrdU antibody (Dako Corp., Carpinteria, CA, USA) according to the supplied protocol. Hepatocyte proliferation was measured by calculating the mean number of hepatocytes with positive BrdU nuclear staining in eight 100× microscopic fields.
 
Quantitative real-time PCR
Total RNA was extracted from cells using Trizol reagent kit (Gibco BRL, Gaithersburg, MD, USA) according to the manufacturer's instructions. After quantification, complementary DNA (cDNA) was synthesized from 2 µg of total RNA using a Takara RNA PCR kit (Takara Bio Inc., Dalian, China) according to manufacturer's instructions. The primers were designed by Primer Premier Version 5.0 and synthesized by Sangon Biotech (Shanghai, China) (Table). The PCR was performed as follows: initial denaturation at 95 �� for 5 minutes, 40 cycles of 20 seconds at 94 ��, 20 seconds at 61 �� for primer annealing extension. β-actin was used as control (mock).
 
Western blotting analysis
Total protein was extracted from the treated cells using RIPA lysis buffer (Beyotime Biotechnology, Haimen, China) supplemented with 1 mmol/L phenyl­methanesulfonyl fluoride. The protein concentration was measured with BCA protein assay system (Beyotime Biotechnology, Haimen, China). Total proteins (40-50 µg) were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred onto polyvinylidene fluoride (PVDF) membranes. The blots were blocked with 5% skim milk in Tris-buffered saline containing 0.1% Tween-20 (TBST) for 2 hours at room temperature, incubated with primary antibodies against ZBTB20 (Abcam Inc., Cambridge, UK) (1:500), AFP (Abcam Inc., Cambridge, UK) (1:1000), and GPC3 (Abcam Inc., Cambridge, UK) (1:1000). β-actin (Zhongshan Golden Bridge Biotech, Beijing, China) (1:10 000) was used as a loading control. The membranes were incubated with the respective primary antibodies overnight at 4 ��. They were washed in TBST for three times and then incubated with horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG (Zhongshan Golden Bridge Biotech, Beijing, China) (1:10 000) for 1 hour at room temperature. The protein bands were detected using the Super Signal West Pico Chemiluminescent Substrate (Thermo Fisher Scientific Inc., Rockford, IL, USA) and visualized using a VersaDoc Imaging System (Bio-Rad Laboratories Co., Ltd., Hercules, CA, USA). Densitometric analysis was performed using Quantity One Software v4.62 (Bio-Rad Laboratories Co., Ltd., Hercules, CA, USA) and the results were presented as the mean of three independent experiments.
 
Statistical analysis
Data were expressed as mean±SD. SPSS Software (SPSS, Chicago, IL, USA) was used for statistical analyses. Analysis of variance (ANOVA) was used for comparisons. All P values were two-tails and considered to be statistically significant when P<0.05.
 
 
Results
Liver regeneration after partial hepatectomy
The ratio of the liver to body weight was significantly increased at the point of 48 hours post major hepatectomy compared to that at the point of 24 hours. However, the ratio did not change significantly in the minor hepatectomy group. Seven days after surgery, there was no significant difference in the liver/body weight ratio between the two groups, indicating that the recovery of the rodent liver was about one week (Fig. 2). BrdU staining showed that the number of BrdU positive cells was significantly increased in the liver tissue at 24, 72, and 168 hours after hepatectomy compared with that in the controls. BrdU positive cells peaked at 72 hours after hepatectomy (Fig. 3).
 
AFP and GPC3 mRNA transcriptions were increased in parallel with liver regeneration
AFP mRNA level exhibited a gradual increase in the major hepatectomy group and reached a significant level after 24 hours compared with the minor hepatectomy group. AFP peaked at 72 hours after major hepatectomy and then dropped rapidly toward normal value (Fig. 4A). The trend of GPC3 mRNA expression was similar to that of AFP. In the minor hepatectomy group, the AFP and GPC3 mRNA levels did not change significantly at the different time points (Fig. 4A, B).
 
ZHX2 and ZBTB20 mRNA transcriptions
On the contrary, both ZHX2 and ZBTB20 mRNA transcriptions in the major hepatectomy group were decreased after partial hepatectomy and reached a significant level in 24 hours compared with the minor hepatectomy group in which there were no significant changes at each time point. Both ZHX2 and ZBTB20 mRNA transcriptions increased back toward normal in 72 hours after major hepatectomy (Fig. 4C, D).
 
ZBTB20 knockdown increased AFP and GPC3 expres­sions and enhanced the proliferation of TIB-73 hepatocytes
To verify that ZBTB20 was a negative regulator of AFP and GPC3, we conducted a knockdown experiment with the siRNA technique. TIB-73 cells were stably transfected with ZBTB20 siRNA-expressing adenovirus, which was confirmed by detection of GFP (Fig. 5A). The marked knockdown of ZBTB20 (>85%) at mRNA (Fig. 5B) and protein (Fig. 5C) levels were detected by real-time PCR and Western blotting analysis.
 
In the cells with confirmed knockdown of ZBTB20, we observed a significant increase in AFP and GPC3 (Fig. 5D). Knockdown of ZBTB20 also promoted the proliferation of TIB-73 cells. The cell number in the three groups (TIB-73+Ad/ZBTB20 siRNA, TIB-73+Ad/siRNA, and TIB-73) was calculated every day. The growth rate of cells with confirmed knockdown of ZBTB20 was significantly higher than that of the other two groups in 24 hours after transfection (Fig. 6).
 
 
Discussion
To our knowledge, this is the first study to investigate the association of ZBTB20 and liver regeneration. We found that ZBTB20 significantly repressed AFP and GPC3 expressions as well as liver regeneration. ZBTB20 knockdown significantly increased AFP and GPC3 expressions and enhanced hepatocytes proliferation.
 
Liver regeneration is a fundamental response to hepatic damage and has been extensively studied since the two-thirds partial hepatectomy model in rodents was described.[1] The advantage of this animal model over administration with carbon tetrachloride (CCl4) is that in partial hepatectomy, all hepatocytes are exposed to the same stimuli resulting in less heterogeneity. The liver regeneration generally reached completeness within one week in this study, which is consistent with what was reported in the literature.[1]
 
Several factors have been identified to be necessary for quiescent mature hepatocytes to rapidly reenter the cell cycle and proliferate to restore the original liver mass. AFP was reported at a high level in the visceral endoderm of the yolk sac and fetal liver, but rapidly repressed after birth and remained at an extremely low level in normal liver tissue.[2, 3] However, this repression is reversible as the AFP gene can be re-activated during liver regeneration and hepatocellular carcinoma. Thus, it has been proposed that AFP transcription level is correlated to the proliferation of hepatocytes.[16]
 
GPC3 was discovered as a potential serological and histochemical marker for hepatocellular carcinoma.[17] Because the expression of the GPC3 gene is active in fetal liver and hepatocellular carcinoma but silent in normal adult liver, it seems reasonable that it shared the same pattern of regulation with AFP.[18] In accordance with other's findings,[10, 11] we found that AFP and GPC3 mRNA levels began to significantly increase in 24 hours after major hepatectomy and peaked at 72 hours, then dropped dramatically from 72 to 168 hours.
 
On the contrary, we observed that ZHX2 level was significantly declined at 24 and 48 hours in the major hepatectomy group whereas the levels of AFP and GPC3 elevated significantly. At 48 hours after operation, the expression of ZHX2, similar to that of AFP and GPC3, returned to the normal level. Our findings suggested that liver regeneration induced the repression of ZHX2 and inversely promoted the expression of AFP and GPC3 (24 to 72 hours post-hepatectomy), which was consistent with previous studies and confirmed that ZHX2 is an important repressor of AFP in postnatal mouse liver.[12, 13]
 
ZBTB20 was initially described as one of a series of genes expressed in human dendritic cells.[19] The proteins belong to the ZBTB family contain an N-terminal BTB (Broad complex, tramtrack, bric-a-brac) domain and multiple C-terminal Kruppel-like C2H2 zinc fingers which often act as transcriptional repressors.[20] Wang et al[21] have reported that ZBTB20 increased in hepatocellular carcinoma and was inversely related to AFP expression in tumor tissue, which was in keeping with our findings.
 
The changes in mRNA expression observed after partial hepatectomy prompted us to speculate that ZBTB20 was another negative regulator of AFP and GPC3 genes in addition to ZHX2. To verify this, siRNA targeting ZBTB20 mRNA was constructed and introduced into TIB-73 cells by adenovirus. Knockdown of ZBTB20 in TIB-73 cells led to significantly higher expression of AFP and GPC3 and higher cell growth rate (24 hours after transfection).
 
There was still some deficiency in this work. AFP activation in C57BL/6J mice is lower than that in other mouse strains due to a genetically unlinked transacting locus, Afr2 (alpha-fetoprotein regulator 2),[22] thus we are going to investigate the other mouse strains. What's more, the mechanism of how hepatectomy starts repression of zinc finger protein genes is still worth exploring.
 
In summary, there were inverse correlations between ZHX2, ZBTB20 and AFP, GPC3 at 24 to 72 hours after major hepatectomy in our rodent model. We found that in liver regeneration after 70% hepatectomy, the decrease of ZBTB20 expression would consequently promote the expression of AFP and GPC3 as well as hepatocytes proliferation.
 
 
References
1 Michalopoulos GK. Liver regeneration. J Cell Physiol 2007;213:286-300. PMID: 17559071
2 Terentiev AA, Moldogazieva NT. Alpha-fetoprotein: a renaissance. Tumour Biol 2013;34:2075-2091. PMID: 23765762
3 Bi Y, He Y, Huang JY, Xu L, Tang N, He TC, et al. Induced maturation of hepatic progenitor cells in vitro. Braz J Med Biol Res 2013;46:559-566. PMID: 23903683
4 Yang D, Yang J, Lu F, Li C, Yang J, Liang J. A new membrane re-anchored protein originating from GPC3 against hepatoma cells HepG2. Mol Med Rep 2011;4:1067-1073. PMID: 21904776
5 Buchanan C, Stigliano I, Garay-Malpartida HM, Rodrigues Gomes L, Puricelli L, Sogayar MC, et al. Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways. Breast Cancer Res Treat 2010;119:559-574. PMID: 19288189
6 Suzuki S, Yoshikawa T, Hirosawa T, Shibata K, Kikkawa F, Akatsuka Y, et al. Glypican-3 could be an effective target for immunotherapy combined with chemotherapy against ovarian clear cell carcinoma. Cancer Sci 2011;102:1622-1629. PMID: 21668581
7 Anchala PR, Dhir R, Parwani AV, Zynger DL. Immunohisto­chemical profile of paratesticular serous papillary adeno­carcinoma and tunica vaginalis facilitates distinction from malignant mesothelioma. Int J Surg Pathol 2011;19:692-698. PMID: 19493919
8 Yao M, Yao DF, Bian YZ, Wu W, Yan XD, Yu DD, et al. Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2013;12:171-179. PMID: 23558072
9 Mneimneh W, Farges O, Bedossa P, Belghiti J, Paradis V. High serum level of alpha-fetoprotein in focal nodular hyperplasia of the liver. Pathol Int 2011;61:491-494. PMID: 21790865
10 Meier V, Tron K, Batusic D, Elmaouhoub A, Ramadori G. Expression of AFP and Rev-Erb A/Rev-Erb B and N-CoR in fetal rat liver, liver injury and liver regeneration. Comp Hepatol 2006;5:2. PMID: 16822301
11 Liu B, Paranjpe S, Bowen WC, Bell AW, Luo JH, Yu YP, et al. Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation. Am J Pathol 2009;175:717-724. PMID: 19574424
12 Belayew A, Tilghman SM. Genetic analysis of alpha-fetoprotein synthesis in mice. Mol Cell Biol 1982;2:1427-1435. PMID: 6186903
13 Perincheri S, Dingle RW, Peterson ML, Spear BT. Hereditary persistence of alpha-fetoprotein and H19 expression in liver of BALB/cJ mice is due to a retrovirus insertion in the Zhx2 gene. Proc Natl Acad Sci U S A 2005;102:396-401. PMID: 15626755
14 Morford LA, Davis C, Jin L, Dobierzewska A, Peterson ML, Spear BT. The oncofetal gene glypican 3 is regulated in the postnatal liver by zinc fingers and homeoboxes 2 and in the regenerating liver by alpha-fetoprotein regulator 2. Hepatology 2007;46:1541-1547. PMID: 17668883
15 Xie Z, Zhang H, Tsai W, Zhang Y, Du Y, Zhong J, et al. Zinc finger protein ZBTB20 is a key repressor of alpha-fetoprotein gene transcription in liver. Proc Natl Acad Sci U S A 2008; 105:10859-10864. PMID: 18669658
16 Assimakopoulos SF, Tsamandas AC, Alexandris IH, Georgiou C, Vagianos CE, Scopa CD. Stimulation of oval cell and hepatocyte proliferation by exogenous bombesin and neurotensin in partially hepatectomized rats. World J Gastrointest Pathophysiol 2011;2:146-154. PMID: 22180848
17 Yao M, Yao DF, Bian YZ, Zhang CG, Qiu LW, Wu W, et al. Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2011;10:289-294. PMID: 21669573
18 Hippo Y, Watanabe K, Watanabe A, Midorikawa Y, Yamamoto S, Ihara S, et al. Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma. Cancer Res 2004;64:2418-2423. PMID: 15059894
19 Zhang W, Mi J, Li N, Sui L, Wan T, Zhang J, et al. Identification and characterization of DPZF, a novel human BTB/POZ zinc finger protein sharing homology to BCL-6. Biochem Biophys Res Commun 2001;282:1067-1073. PMID: 11352661
20 Peterson ML, Ma C, Spear BT. Zhx2 and Zbtb20: novel regulators of postnatal alpha-fetoprotein repression and their potential role in gene reactivation during liver cancer. Semin Cancer Biol 2011;21:21-27. PMID: 21216289
21 Wang Q, Tan YX, Ren YB, Dong LW, Xie ZF, Tang L, et al. Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis. BMC Cancer 2011;11:271. PMID: 21702992
22 Jin DK, Feuerman MH. Genetic mapping of Afr2 (Rif): regulator of gene expression in liver regeneration. Mamm Genome 1998;9:256-258. PMID: 9501315
 
Received August 30, 2013
Accepted after revision November 17, 2013